Yang Yang

Yang Yang

Auto-generated profile, based on publicly available information

Yang Yang

The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, 100853, People’s Republic of China

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2026 in Clinical Interventions in Aging
Verified
Journal Article
Open access
PDF file
YDYingzhen Du
Yingzhen Du
YYYang Yang
Yang Yang
YZYu Zhou
Yu Zhou
XHXinjie Han
Xinjie Han
ZYZhenghao Yu
Zhenghao Yu
GXGuogang Xu
Guogang Xu
Background: High-flow nasal cannula (HFNC) oxygen therapy provides effective respiratory support with enhanced comfort and airway humidification. Long-term use of HFNC is increasingly adopted in respiratory oxygen therapy for elderly patients, yet Catheter-related bacterial translocation and colonization risks remain unstudied. Methods: This prospective study enrolled 102 elderly hospitalized patients (mean age: 94.2 ± 5.1 years old) receiving HFNC therapy. Microbial samples were collected from the HFNC circuits and analyzed to assess respiratory circuit colonization. The optimal tubing replacement interval was determined through ROC curve analysis. Additionally, for one patient who developed pulmonary infection after receiving HFNC, microbial homology was evaluated between microorganisms cultured isolates from the lower respiratory tract and those from the HFNC tubing using whole-genome sequencing and antibiotic resistance gene profiling. Results: Microbial colonization of HFNC tubing was detected in 56.9% (58/102) of patients, with prevalent pathogens including Filamentous fungi (25.9%), Methicillin-resistant Staphylococcus aureus (20.7%), and Streptococcus spp. (13.8%). The median time to tubing colonization was 136.2 ± 58.2 days. Pulmonary infections occurred significantly more frequently in the culture-positive group (37/58=63.8%) compared to the culture-negative group (17/44=38.6%; P = 0.016). ROC analysis identified 90.5 days as the study-specific optimal cutoff associated with tubing contamination. In the case study, Pseudomonas aeruginosa was isolated from both the patient’s lower respiratory tract and HFNC tubing. Homology analysis confirmed the strains were identical (ST2069, O6 serotype) and harbored six shared resistance genes (aph(3′)-IIb, crpP, catB7, blaPAO, blaOXA-488, fosA). Conclusion: Prolonged HFNC use was associated with substantial microbial colonization of the circuit in elderly hospitalized patients. Replacing HFNC tubing at approximately 90-day intervals may reduce microbial colonization and pneumonia risk in elderly patients during HFNC therapy. The HFNC tube circuit serves as a potential reservoir for pathogenic translocation, highlighting the importance of timely tubing replacement and microbial monitoring of the tube in infection prevention protocols.

1 February 2026 in Clinical Interventions in Aging
Verified
Journal Article
Open access
PDF file
TLTingting Liu
Tingting Liu
ZLZeyang Li
Zeyang Li
GWGe Wei
Ge Wei
YYYang Yang
Yang Yang
FWFang Wang
Fang Wang
XFXiangqun Fang
Xiangqun Fang
Background: Elderly patients are at increased risk of infection with methicillin-resistant Staphylococcus aureus (MRSA). Therefore, this article comprehensively reviews the progress in therapeutic drug monitoring (TDM) and pharmacokinetic (PK) studies of linezolid, contezolid and tedizolid in the elderly population, to inform individualized dosing strategies. Methods: This review synthesized evidence from published and ongoing studies examining the TDM and PK studies of linezolid, contezolid and tedizolid in elderly patients, encompassing investigations into drug concentrations monitoring, PK parameters, and population PK studies. No date restrictions were applied to the study selection. Results: The distinct pathophysiology of elderly patients leads to significant alterations in the PK characteristics of various antibacterial agents, necessitating individualized dosage adjustments. In this population, linezolid exhibits a prolonged half-life, markedly decreased clearance, and elevated risk of severe overexposure. Therefore, its dosage requires adjustment based on renal function and age. Contezolid exhibits comparable pharmacokinetics in patients aged 65– 74 years to younger adults; however, in patients aged 80 and above, its time to peak concentration is delayed, elimination is accelerated, while Cmax and AUC0-t increase dose-dependently. Tedizolid plasma exposure was similar in elderly and younger control subjects, indicating that no dose adjustment was warranted for elderly subjects. Moreover, contezolid and tedizolid exhibit a more favorable safety profile compared with linezolid. Conclusion: The PK characteristics of oxazolidinone antibiotics may be altered in the elderly population. TDM and model-informed precision dosing (MIPD) are crucial approaches for achieving individualized dosing strategies.

1 October 2026 in Clinical Interventions in Aging
Verified
Journal Article
Open access
PDF file
ZYZhenghao Yu
Zhenghao Yu
RLRong Li
Rong Li
XWXi Wang
Xi Wang
YZYu Zhou
Yu Zhou
XHXinjie Han
Xinjie Han
YDYingzhen Du
Yingzhen Du
Background: Bloodstream infections (BSIs) in elderly patients are associated with heightened mortality risks. This study aimed to characterize clinical profiles and identify predictors of mortality in this at-risk population. Methods: In this 12 years retrospective cohort study, elderly patients (≥ 65 years) with BSI (mean age 89.9 ± 8.5 years), admitted to a tertiary geriatric hospital in Beijing, China from December 2011 to February 2024, were enrolled. Comprehensive analyses of clinical characteristics, microbiological profiles, and laboratory parameters were performed. Multivariable logistic regression analysis was performed to assess mortality-associated risk factors. Additionally, receiver operating characteristic (ROC) curve analysis was used to assess the diagnostic utility of various laboratory biomarkers. Results: A total of 527 elderly patients (mean age 89.9 ± 8.5 years) were included in the final analysis, among whom 440 (83.5%) survived and 87 (16.5%) died. Multivariate analysis revealed that prolonged mechanical ventilation was strongly associated with the highest risk of all-cause mortality, with escalating risks observed in duration-dependent patterns:1-30 days (odds ratio [OR], 12.70; 95% confidence interval [CI], 5.86– 29.00; P < 0.001) and 31– 90 days (OR, 3.21; 95% CI, 1.53– 6.89; P = 0.002). Additional independent risk factors for all-cause mortality included: the use of central venous catheterization (1– 60 days) (OR, 2.56; 95% CI, 1.05– 6.72; P = 0.045) and urinary catheterization (1– 60 days) (OR, 2.28; 95% CI, 1.13– 4.62; P = 0.021), chemotherapy or radiotherapy (OR, 3.25; 95% CI, 1.42– 7.43; P = 0.005). ROC curve analysis demonstrated platelet count as the most discriminative prognostic marker, with an area under the curve (AUC) of 0.79, a Youden index of 0.53, sensitivity of 58.3%, and specificity of 94.2%. Conclusions: Prolonged invasive medical interventions, including mechanical ventilation, central venous catheterization, and urinary catheterization, as well as chemotherapy or radiotherapy, were independently associated with higher mortality in elderly BSI patients. These findings highlight the need for risk-stratified management strategies to optimize outcomes in these elderly patients.